Related references
Note: Only part of the references are listed.NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients
Luis Jaramillo-Valverde et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2022)
Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients
Kelly S. Levano et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2021)
Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil
Carolline Araujo-Mariz et al.
ANNALS OF HEPATOLOGY (2020)
GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug-induced liver injury
Noppadol Chanhom et al.
BIOMEDICAL REPORTS (2020)
Evolutionary genomic dynamics of Peruvians before, during, and after the Inca Empire
Daniel N. Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Genetics and genomics in Peru: Clinical and research perspective
Heinner Guio et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
NAT2 gene diversity and its evolutionary trajectory in the Americas
R. Bisso-Machado et al.
PHARMACOGENOMICS JOURNAL (2016)
Evaluation of the use of clinical decision support and online resources for pharmacogenomics education
Carolyn R. Rohrer Vitek et al.
PHARMACOGENOMICS (2015)
Personalized Medicine and Human Genetic Diversity
Yi-Fan Lu et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis
C. Li et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
GSTM1 and GSTT1 null polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis
N. Tang et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs
Julian G. Chamorro et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management
Vidyasagar Ramappa et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2013)
Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population
Vinod H. Gupta et al.
ANNALS OF HEPATOLOGY (2013)
CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study
S. -W. Tang et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population
Xiaozhen Lv et al.
ANNALS OF HEPATOLOGY (2012)
Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients
Getnet Yimer et al.
PLOS ONE (2011)
Frequency distribution of GSTM1 and GSTT1 null allele in Pakistani population and risk of disease incidence
Rehan Sadiq Shaikh et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2010)
GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs
S. Chatterjee et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans
Sang-Heon Kim et al.
TUBERCULOSIS (2010)
Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil
L. G. Possuelo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population
Virginia Leiro et al.
LIVER INTERNATIONAL (2008)
NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan
Chi-Chou Huang et al.
DISEASES OF THE COLON & RECTUM (2007)
Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury
Yi-Shin Huang et al.
JOURNAL OF HEPATOLOGY (2007)
Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity
S. Fuselli et al.
PHARMACOGENOMICS JOURNAL (2007)
Pharmacogenomics in the Americas: The impact of genetic admixture
G. Suarez-Kurtz et al.
CURRENT DRUG TARGETS (2006)
Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology
H. M. Bolt et al.
CURRENT DRUG METABOLISM (2006)
Pharmacogenomics: Bench to bedside
R Weinshilboum et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia
MT Voso et al.
BLOOD (2002)
Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1
D Haase et al.
LEUKEMIA RESEARCH (2002)
Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation
B Roy et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity
T Simon et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Glutathione S-transferase: genetics and role in toxicology
RC Strange et al.
TOXICOLOGY LETTERS (2000)
Share Paper
